BCR and cancer: It not only provided the latest insights to the correlations between cancer cells and TME cells, but most importantly, it proposed a method for screening high-risk BCR patients at the genetic level, which was helpful for individualized screening of early treatment patient groups, and ultimately helped to reduce PCa medical costs.